Doctorglasses Chain Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002PH4
CNY
25.73
0.38 (1.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
353.21
279.89
394.12
360.21
326.16
287.55
314.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
353.21
279.89
394.12
360.21
326.16
287.55
314.32
Raw Material Cost
148.22
45.54
197.17
182.31
144.51
90.34
136.71
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.86
0.63
1.62
2.05
2.17
1.48
2.64
Selling and Distribution Expenses
153.39
159.21
155.81
144.88
140.95
157.50
139.22
Other Expenses
-0.14
-0.01
-0.12
-0.15
-0.16
-0.09
-0.20
Total Expenditure (Excl Depreciation)
302.07
205.26
353.45
327.70
285.98
248.44
276.52
Operating Profit (PBDIT) excl Other Income
51.1
74.6
40.7
32.5
40.199999999999996
39.1
37.8
Other Income
1.12
0.29
1.34
3.48
2.70
7.78
4.05
Operating Profit (PBDIT)
48.68
95.50
78.04
72.68
77.97
68.37
81.05
Interest
1.86
0.63
1.62
2.05
2.17
1.48
2.64
Exceptional Items
5.09
20.03
0.73
2.18
1.45
0.14
0.24
Gross Profit (PBDT)
205.00
234.35
196.95
177.90
181.65
197.21
177.61
Depreciation
0.00
36.95
36.95
38.11
38.11
40.77
40.77
Profit Before Tax
51.92
77.95
40.20
34.70
39.14
26.24
37.87
Tax
10.47
15.84
7.04
7.40
8.02
7.72
7.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
39.91
60.77
31.80
25.86
30.18
20.14
31.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
39.91
60.77
31.80
25.86
30.18
20.14
31.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.54
1.33
1.36
1.45
0.95
-1.63
-0.36
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.45
62.11
33.16
27.30
31.12
18.52
30.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
946.91
908.23
848.06
816.18
790.61
760.63
786.84
Earnings per share (EPS)
0.17
0.27
0.14
0.11
0.13
0.09
0.14
Diluted Earnings per share
0.17
0.27
0.14
0.11
0.13
0.09
0.14
Operating Profit Margin (Excl OI)
13.47%
20.81%
10.08%
8.63%
11.39%
6.89%
11.52%
Gross Profit Margin
14.7%
41.05%
19.57%
20.21%
23.69%
23.31%
25.02%
PAT Margin
11.3%
21.71%
8.07%
7.18%
9.25%
7.01%
9.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 26.19% vs -28.98% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -33.33% vs 87.05% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -50.00% vs 24.12% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 216.67% vs -62.50% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Doctorglasses Chain Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
353.21
0
353.21
Other Operating Income
0.00
0.00
0.00
Total Operating income
353.21
0
353.21
Raw Material Cost
148.22
0
148.22
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.86
0
1.86
Selling and Distribution Expenses
153.39
0
153.39
Other Expenses
-0.14
0.00
-0.14
Total Expenditure (Excl Depreciation)
302.07
0
302.07
Operating Profit (PBDIT) excl Other Income
51.14
0.00
51.14
Other Income
1.12
0
1.12
Operating Profit (PBDIT)
48.68
0
48.68
Interest
1.86
0
1.86
Exceptional Items
5.09
0
5.09
Gross Profit (PBDT)
205.00
0
205.00
Depreciation
0.00
0
0.00
Profit Before Tax
51.92
0
51.92
Tax
10.47
0
10.47
Provisions and contingencies
0
0
0.00
Profit After Tax
39.91
0
39.91
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
39.91
0
39.91
Share in Profit of Associates
0
0
0.00
Minority Interest
1.54
0
1.54
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.45
0
41.45
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
946.91
0
946.91
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
13.47%
0%
0.00
13.47%
Gross Profit Margin
14.70%
0%
0.00
14.70%
PAT Margin
11.30%
0%
0.00
11.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 35.32 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 26.19% vs -28.98% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 8.28% vs 10.24% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.14 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -33.33% vs 87.05% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 33.12% vs 23.41% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.76 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -50.00% vs 24.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -36.79% vs 7.57% in Mar 2025

Quarterly - Interest
Interest 0.19 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 216.67% vs -62.50% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -13.64% vs 10.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.47%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025